Related Experiment Video
Updated: May 18, 2026

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Global secretome characterization of herpes simplex virus 1-infected human primary macrophages
Juho J Miettinen1, Sampsa Matikainen, Tuula A Nyman
1Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Abstract:
Herpes simplex virus 1 (HSV-1) is a common pathogen infecting the majority of people worldwide at some stage in their lives. The early host response to viral infection is initiated by the cells of the innate immune response, including macrophages. Here, we have characterized the secretome of HSV-1-infected human primary macrophages using high-throughput quantitative proteomics. We identified and quantified 516 distinct human proteins with high confidence from the macrophage secretome upon HSV-1 infection, and the secretion of 411 proteins was >2-fold increased upon beta interferon (IFN-β) priming and/or HSV-1 infection. Bioinformatics analysis of the secretome data revealed that most of the secreted proteins were intracellular, and almost 80% of the proteins whose secretion increased more than 2-fold were known exosomal proteins. This strongly suggests that nonclassical, vesicle-mediated protein secretion is activated in IFN-β-primed and HSV-1-infected macrophages. Proteins related to immune and inflammatory responses, interferon-induced proteins, and endogenous danger signal proteins were efficiently secreted upon IFN-β priming and HSV-1 infection. The secreted IFN-induced proteins include interferon-induced tetratricopeptide protein 2 (IFIT2), IFIT3, signal transducer and activator of transcription 1 (STAT1), and myxovirus resistance protein A (MxA), implicating that these proteins also have important extracellular antiviral functions. Proinflammatory cytokine interleukin-1β was not released by HSV-1-infected macrophages, demonstrating that HSV-1 can antagonize inflammasome function. In conclusion, our results provide a global view of the secretome of HSV-1-infected macrophages, revealing host factors possibly having a role in antiviral defense.
Insights
Herpes simplex virus 1 (HSV-1) infection activates macrophages to secrete proteins, many via exosomes. This antiviral defense mechanism involves interferon-induced proteins but HSV-1 blocks interleukin-1β release.
Area of Science:
- Immunology
- Virology
- Proteomics
Background:
- Herpes simplex virus 1 (HSV-1) is a widespread pathogen.
- Macrophages are key cells in the innate immune response to viral infections.
Purpose of the Study:
- To characterize the protein secretion (secretome) of human macrophages in response to HSV-1 infection.
- To investigate the role of interferon-beta (IFN-β) priming in modulating the macrophage secretome during HSV-1 infection.
Main Methods:
- High-throughput quantitative proteomics was used to analyze the secretome of HSV-1-infected human primary macrophages.
- Bioinformatics analysis was performed on the identified proteins.
Main Results:
- 516 human proteins were identified in the macrophage secretome upon HSV-1 infection.
- Secretion of 411 proteins increased >2-fold with IFN-β priming and/or HSV-1 infection.
- 80% of highly secreted proteins were exosomal, indicating activation of nonclassical, vesicle-mediated secretion.
- Secreted proteins included immune response factors, interferon-induced proteins (e.g., IFIT2, IFIT3, STAT1, MxA), and danger signal proteins.
- Interleukin-1β was not released, suggesting HSV-1 antagonizes inflammasome activity.
Conclusions:
- HSV-1 infection and IFN-β priming induce a significant, nonclassical secretion of proteins from macrophages.
- Secreted interferon-induced proteins may possess extracellular antiviral functions.
- HSV-1 actively inhibits inflammasome activation by preventing interleukin-1β release.

